Our Shield™ blood test gains FDA approval, ushering in a new era of colorectal cancer screening.  More Details

ahuebner@guardanthealth.com

Cancer cells
September 11, 2024

Opinion | Science Finds New Ways to Detect Cancer, but Politics Gets in the Way

Shield blood test box.
August 5, 2024

FDA Approves Blood Test for Colon Cancer Detection

Cancer cells.
July 16, 2024

It’s Time for a New Option in Colorectal Cancer Screening

STAT reporter Nicholas St. Fleur talks with Guardant Health co-CEO Helmy Eltoukhy about patient access to precision oncology testing.
July 10, 2024

Blood Tests for Cancer Patients Save Lives. Access Remains an Issue.

Guardant signage outside company headquarters
June 11, 2024

FDA Advisory Committee Strongly Recommends Approval For Guardant Health Blood Test For Colorectal Cancer

Panel recommends approval of Shield as primary non-invasive screening option in adults aged 45 and older at average risk for the disease

Guardant Health male lab technician
May 30, 2024

TIME100 Most Influential Companies 2024: Guardant Health

Shield blood test box.
May 23, 2024

F.D.A. Panel Endorses Safety of Colon-Cancer Blood Test

Clinician and patient discussing with a tablet.
May 21, 2024

Let’s Enter a New Era of Options for Colorectal Cancer Screening

Colorectal cancer is the second-leading cause of cancer death in the United States. Rates are rising in younger – and middle-aged individuals.

Blood vials on a piece of paper.
May 13, 2024

Guardant Health Preps for FDA Advisory Panel Review of its Blood-Based Colorectal Cancer Screening Test

Female lab tech.
April 17, 2024

Leveling the Health Care Playing Field through Emerging Technology